Unverified50% confidenceOpinionExact time
The AI drug discovery field lacks unified evaluation standards, making it difficult to compare different research results side by side.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/22/2026
First Seen
Valid until: 1/20/2027
Sources
Related Entities
Related Claims
UnverifiedAI生图的评价标准正在从好不好看向真不真迁移79% similarVerifiedCurrently, there is no widely recognized evaluation framework in the industry capable of comprehensively measuring the overall intelligence of AI.77% similarUnverifiedMost consumer-grade AI systems lack clinical validation, and their recommendations are based more on correlation than on causation.77% similarUnverifiedThe AI field still lacks an independent review mechanism comparable to financial or pharmaceutical regulation.77% similarVerifiedCommon friction points in AI feature acceptance include lack of consensus on evaluation criteria, high cost of constructing test data, and difficulty quantifying subjective quality.76% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1085194API
curl https://kongchang.com/api/v1/knowledge/claims/1085194MCP
get_claim(id=1085194)